+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Wearable Artificial Kidney Market by Therapy Type, End User, Distribution Channel, Technology, Age Group - Global Forecast to 2030- Product Image
Wearable Artificial Kidney Market by Therapy Type, End User, Distribution Channel, Technology, Age Group - Global Forecast to 2030- Product Image
Sale

Wearable Artificial Kidney Market by Therapy Type, End User, Distribution Channel, Technology, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5612818
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Wearable Artificial Kidney Market grew from USD 213.08 million in 2024 to USD 255.20 million in 2025. It is expected to continue growing at a CAGR of 18.86%, reaching USD 600.97 million by 2030.

Unlocking the Future of Kidney Care with Wearable Technology

The convergence of miniaturization, biocompatibility, and advanced filtration technology has catalyzed a new paradigm in renal care-one that shifts treatment from stationary clinics into the daily lives of patients. Wearable artificial kidneys are at the forefront of this revolution, offering continuous clearance of toxins, enhanced patient autonomy, and the promise of improved health outcomes. As chronic kidney disease prevalence continues to rise globally, the imperative for solutions that minimize hospital visits and elevate quality of life has never been stronger.

Against this backdrop, the wearable artificial kidney transcends its role as a novel medical device to become a symbol of patient-centered innovation. It embodies a transition from rigid treatment schedules to flexible, on-the-go therapies that integrate with diverse lifestyles. This evolution not only addresses the clinical burden on healthcare systems but also empowers individuals to reclaim control over their daily routines. This introduction frames the journey ahead, one that charts technological breakthroughs, market dynamics, and strategic inflection points shaping the wearable artificial kidney ecosystem.

Pivotal Transformations Redefining Kidney Treatment Approaches

The landscape of renal therapy is undergoing seismic shifts driven by breakthroughs in sensor technology, bioengineered membranes, and digital connectivity. Continuous monitoring capabilities integrated into wearable artificial kidneys enable real-time adjustments that optimize toxin clearance while safeguarding hemodynamic stability. Meanwhile, the integration of artificial intelligence algorithms accelerates the move toward predictive maintenance and personalized treatment regimens tailored to each patient’s unique physiology.

Parallel to these technological advances, healthcare delivery models are evolving. The migration of care from centralized dialysis centers to home- and community-based settings is dismantling legacy barriers and fostering greater patient engagement. This transformation is supported by evolving reimbursement frameworks that recognize the cost benefits of reduced hospitalization and lower complication rates. Collectively, these developments are redefining the renal therapy paradigm, shifting the focus from episodic intervention to seamless, continuous care.

Assessing the Impact of United States Tariffs on the Market in 2025

The imposition of new tariffs in the United States during 2025 has introduced critical considerations for device manufacturers, component suppliers, and end users alike. Increased duties on imported filtration membranes and electronic modules have elevated production costs, prompting a reevaluation of global supply chain strategies. In response, some manufacturers have accelerated efforts to localize component sourcing, while others are exploring alternative materials that balance performance with affordability.

These tariff-induced cost pressures have also influenced pricing negotiations with payers and healthcare providers. As procurement budgets tighten, stakeholders must demonstrate clear value propositions-namely improved patient outcomes, lower total cost of care, and enhanced device utilization rates. The ripple effects of the tariff landscape extend to distribution channels as well, with amplified interest in domestic partnerships and joint ventures designed to mitigate exposure to import-related expenses. Navigating this complex environment demands agility and foresight from industry participants across the value chain.

Deep Dive into Market Segmentation Reveals Growth Drivers

Analyzing the wearable artificial kidney market through multiple segmentation lenses unveils the diverse needs and growth trajectories across patient populations and care settings. The therapy spectrum spans hemodialysis-with both conventional and ultraportable modalities-and peritoneal dialysis options that include automated systems and continuous ambulatory approaches. End users range from high-volume ambulatory centers to specialized home care providers and hospital clinics, each presenting unique requirements for device portability, ease of operation, and support services.

Channel dynamics split between traditional direct and distributor-led offline sales and the expanding realm of digital commerce, which offers expedited order fulfillment and remote customer engagement. Technological segmentation highlights continuous wear solutions available in extended duration and short duration formats, contrasted against intermittent devices engineered for daily or periodic use. Finally, age group differentiation distinguishes adult patients, who represent the majority of device adoption, from pediatric cohorts that require tailored design considerations and support protocols. This multifaceted segmentation framework illuminates opportunities for targeted product innovation and customized service models.

Regional Dynamics Shaping Wearable Kidney Device Adoption

Regional variations in healthcare infrastructure, reimbursement policies, and patient demographics are shaping the pace and pattern of wearable artificial kidney adoption. In the Americas, robust investment in medical innovation and supportive reimbursement reforms have fostered an environment conducive to early adoption of portable and ultraportable devices. Leading academic medical centers and dialysis networks are increasingly piloting home-based systems, validating both clinical outcomes and patient satisfaction.

Across Europe, the Middle East and Africa, heterogeneous regulation and reimbursement landscapes present both challenges and opportunities. In Western Europe, established universal healthcare frameworks have begun to integrate home-based kidney therapies, while emerging markets in the Middle East and Africa are focusing on public-private partnerships to bridge accessibility gaps. In the Asia-Pacific region, growing incidence rates of chronic kidney disease, coupled with expanding healthcare budgets, are driving local manufacturing initiatives and collaborative research efforts to develop cost-optimized wearable solutions. These regional dynamics underscore the importance of a tailored market entry strategy that aligns with local healthcare priorities and economic conditions.

Competitive Landscape Highlights Leading Innovators

The competitive arena is defined by organizations leveraging multidisciplinary expertise in biomedical engineering, digital health, and renal physiology. Leading players are distinguishing themselves through advanced membrane technologies that offer superior solute clearance and reduced anticoagulation requirements. Others are forging alliances with technology firms to integrate data analytics platforms that deliver actionable insights on device performance and patient adherence.

Strategic partnerships are emerging between established medical device manufacturers and smaller innovators specializing in niche components or software solutions. These collaborations aim to accelerate time-to-market and expand the functional capabilities of wearable artificial kidneys. In parallel, investment activity from venture capital and private equity is fueling late-stage clinical trials and commercialization efforts. Together, these dynamics are creating a vibrant ecosystem where agility and technological differentiation confer competitive advantage.

Strategic Imperatives for Industry Leaders to Seize Opportunities

To capitalize on the momentum surrounding wearable artificial kidneys, industry leaders must adopt a multifaceted approach. First, investing in vertically integrated supply chains will buffer device makers against geopolitical and trade-related disruptions. Cultivating relationships with component suppliers and local manufacturing partners can ensure continuity of supply and cost stability. Second, forging evidence-based partnerships with clinical institutions will generate real-world data that substantiate claims of efficacy and safety, thereby strengthening reimbursement dossiers.

Third, embracing digital health platforms to support remote monitoring, patient education, and telehealth consultations will enhance user engagement and adherence. Fourth, tailoring go-to-market strategies by aligning product portfolios with the specific demands of hospital-centric, home-based, and ambulatory care settings will optimize market penetration. Finally, championing patient-centered service models-such as mobile training units and dedicated support hotlines-will foster long-term loyalty and improve clinical outcomes.

Robust Research Methodology Ensuring Comprehensive Insights

This analysis is grounded in a rigorous, multi-phase research methodology designed to deliver comprehensive market intelligence. Primary data collection involved in-depth interviews with key opinion leaders, including nephrologists, biomedical engineers, and healthcare administrators. Quantitative surveys captured insights from device manufacturers, distributors, and end users across therapy settings. Complementing primary research, secondary sources such as peer-reviewed journals, regulatory filings, and industry white papers were systematically reviewed to validate and enrich findings.

A triangulation approach was employed to cross-verify data points and ensure consistency across multiple sources. Regional market assessments were informed by local regulatory frameworks, reimbursement guidelines, and epidemiological studies. Segmentation analyses integrated both qualitative expert feedback and quantitative usage patterns to map growth opportunities. Throughout the research process, data integrity protocols and quality checks were rigorously applied to uphold accuracy and relevance.

Synthesis of Findings Emphasizes Market Potential

The examination of wearable artificial kidneys reveals a confluence of technological innovation, shifting healthcare delivery models, and dynamic market forces. Advances in membrane science, sensor integration, and data analytics are driving the evolution of portable and wearable systems that promise continuous toxin removal with minimal patient disruption. Regulatory and reimbursement environments are progressively accommodating home-based therapies, while regional variations underscore the necessity of bespoke market entry strategies.

Tariff developments and supply chain considerations highlight the need for strategic resilience, and competitive dynamics illustrate the value of collaboration and differentiation. Segmentation insights illuminate distinct growth drivers across therapy types, end users, distribution channels, technology paradigms, and patient demographics. Together, these findings underscore the vast potential of wearable artificial kidneys to transform renal care, provided stakeholders navigate the complex interplay of innovation, regulation, and market adoption.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Therapy Type
    • Hemodialysis
      • Conventional Hemodialysis
      • Ultraportable Hemodialysis
    • Peritoneal Dialysis
      • Automated Peritoneal Dialysis
      • Continuous Ambulatory Peritoneal Dialysis
  • End User
    • Ambulatory Center
    • Home Care
    • Hospital Clinic
  • Distribution Channel
    • Offline Sales
      • Direct Sales
      • Distributor
    • Online Sales
  • Technology
    • Continuous Wear
      • Extended Duration
      • Short Duration
    • Intermittent Wear
      • Daily Use
      • Periodic Use
  • Age Group
    • Adult
    • Pediatric
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • DaVita Inc.
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Ltd.
  • DiA Imaging Analysis Ltd.
  • Diality GmbH
  • NxStage Medical, Inc.
  • Nipro Corporation
  • Vivance

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Wearable Artificial Kidney Market, by Therapy Type
8.1. Introduction
8.2. Hemodialysis
8.2.1. Conventional Hemodialysis
8.2.2. Ultraportable Hemodialysis
8.3. Peritoneal Dialysis
8.3.1. Automated Peritoneal Dialysis
8.3.2. Continuous Ambulatory Peritoneal Dialysis
9. Wearable Artificial Kidney Market, by End User
9.1. Introduction
9.2. Ambulatory Center
9.3. Home Care
9.4. Hospital Clinic
10. Wearable Artificial Kidney Market, by Distribution Channel
10.1. Introduction
10.2. Offline Sales
10.2.1. Direct Sales
10.2.2. Distributor
10.3. Online Sales
11. Wearable Artificial Kidney Market, by Technology
11.1. Introduction
11.2. Continuous Wear
11.2.1. Extended Duration
11.2.2. Short Duration
11.3. Intermittent Wear
11.3.1. Daily Use
11.3.2. Periodic Use
12. Wearable Artificial Kidney Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Pediatric
13. Americas Wearable Artificial Kidney Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Wearable Artificial Kidney Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Wearable Artificial Kidney Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Baxter International Inc.
16.3.2. B. Braun Melsungen AG
16.3.3. DaVita Inc.
16.3.4. Outset Medical, Inc.
16.3.5. Quanta Dialysis Technologies Ltd.
16.3.6. DiA Imaging Analysis Ltd.
16.3.7. Diality GmbH
16.3.8. NxStage Medical, Inc.
16.3.9. Nipro Corporation
16.3.10. Vivance
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. WEARABLE ARTIFICIAL KIDNEY MARKET MULTI-CURRENCY
FIGURE 2. WEARABLE ARTIFICIAL KIDNEY MARKET MULTI-LANGUAGE
FIGURE 3. WEARABLE ARTIFICIAL KIDNEY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. WEARABLE ARTIFICIAL KIDNEY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ULTRAPORTABLE HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AMBULATORY CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOSPITAL CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY EXTENDED DURATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY SHORT DURATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DAILY USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERIODIC USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 61. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 62. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 65. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 67. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 68. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 75. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 77. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 78. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 120. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 126. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 128. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 129. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 132. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 133. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 136. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 138. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 139. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 150. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 151. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 152. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 153. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 156. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 158. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 159. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 162. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 163. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 166. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 168. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 169. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 200. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 202. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 203. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 206. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 208. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 209. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 221. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 222. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 223. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 226. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 228. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 229. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 230. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 231. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 232. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 233. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 236. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 238. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 239. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 261. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 262. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 263. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 266. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 268. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 269. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 271. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 272. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 273. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 276. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 278. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 279. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 290. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 291. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 292. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 293. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 296. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 298. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 299. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 300. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 301. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 302. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 303. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 306. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 308. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY INTERMITTENT WEAR, 2018-2030 (USD MILLION)
TABLE 309. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 310. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 311. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY CONTINUOUS WEAR, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKE

Companies Mentioned

The companies profiled in this Wearable Artificial Kidney market report include:
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • DaVita Inc.
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Ltd.
  • DiA Imaging Analysis Ltd.
  • Diality GmbH
  • NxStage Medical, Inc.
  • Nipro Corporation
  • Vivance

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 255.2 Million
Forecasted Market Value ( USD ) by 2030 $ 600.97 Million
Compound Annual Growth Rate18.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Wearable Artificial Kidney Market Size, Share & Trends Analysis Report By Patient Type, By Material, By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Wearable Artificial Kidney Market Size, Share & Trends Analysis Report By Patient Type, By Material, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Artificial Kidney Market Report 2025 - Product Image

Artificial Kidney Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Artificial Kidney - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Artificial Kidney - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Digital Platform for Chronic Kidney Disease Market by Component, Application, End User, Deployment Mode, Pricing Model, Delivery Channel - Global Forecast to 2030 - Product Image

Digital Platform for Chronic Kidney Disease Market by Component, Application, End User, Deployment Mode, Pricing Model, Delivery Channel - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Wearable Artificial Organs Market by Artificial Organ, by Technology, by End-user, and By Region - Product Image

Wearable Artificial Organs Market by Artificial Organ, by Technology, by End-user, and By Region

  • Report
  • 200 Pages
  • Global
From

About the Wearable Artificial Kidney Market

The Wearable Artificial Kidney (WAK) is a medical device designed to provide dialysis to patients with end-stage renal disease. It is a portable, battery-powered device that can be worn on the body, allowing patients to move freely while receiving dialysis. The device is designed to mimic the natural functions of the kidneys, filtering waste and excess fluid from the body. It is connected to the patient via a catheter, and the dialysis fluid is circulated through the device. The WAK market is a rapidly growing segment of the medical device industry, with a focus on providing improved quality of life for patients with end-stage renal disease. The device is designed to provide a more comfortable and convenient dialysis experience, allowing patients to move freely and engage in activities that would otherwise be difficult or impossible. Companies in the Wearable Artificial Kidney market include NxStage Medical, Baxter International, Fresenius Medical Care, and Asahi Kasei. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.